DE69927041D1 - Null igf zur krebsbehandlung - Google Patents

Null igf zur krebsbehandlung

Info

Publication number
DE69927041D1
DE69927041D1 DE69927041T DE69927041T DE69927041D1 DE 69927041 D1 DE69927041 D1 DE 69927041D1 DE 69927041 T DE69927041 T DE 69927041T DE 69927041 T DE69927041 T DE 69927041T DE 69927041 D1 DE69927041 D1 DE 69927041D1
Authority
DE
Germany
Prior art keywords
igf
zero
cancer treatment
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69927041T
Other languages
English (en)
Other versions
DE69927041T2 (de
Inventor
Desmond Mascarenhas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celtrix Pharmaceuticals Inc
Original Assignee
Celtrix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/399,120 external-priority patent/US7288516B1/en
Application filed by Celtrix Pharmaceuticals Inc filed Critical Celtrix Pharmaceuticals Inc
Publication of DE69927041D1 publication Critical patent/DE69927041D1/de
Application granted granted Critical
Publication of DE69927041T2 publication Critical patent/DE69927041T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69927041T 1998-10-02 1999-09-29 Null igf zur krebsbehandlung Expired - Fee Related DE69927041T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10274798P 1998-10-02 1998-10-02
US09/399,120 US7288516B1 (en) 1999-09-20 1999-09-20 Null IGF for the treatment of cancer
PCT/US1999/022681 WO2000020023A2 (en) 1998-10-02 1999-09-29 Null igf for the treatment of cancer

Publications (2)

Publication Number Publication Date
DE69927041D1 true DE69927041D1 (de) 2005-10-06
DE69927041T2 DE69927041T2 (de) 2006-06-14

Family

ID=26799690

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69927041T Expired - Fee Related DE69927041T2 (de) 1998-10-02 1999-09-29 Null igf zur krebsbehandlung

Country Status (8)

Country Link
EP (1) EP1117424B1 (de)
JP (1) JP2003522110A (de)
AT (1) ATE303159T1 (de)
AU (1) AU767141B2 (de)
CA (1) CA2345353C (de)
DE (1) DE69927041T2 (de)
HK (1) HK1040906B (de)
WO (1) WO2000020023A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1141014T3 (da) 1999-01-06 2005-04-11 Genentech Inc Insulinlignende vækstfaktor (IGF) i mutantvariant
ATE389416T1 (de) 2000-05-16 2008-04-15 Genentech Inc Behandlung von knorpelerkrankungen
CA2422625A1 (en) 2000-09-19 2002-03-28 Bioexpertise, Llc Method for use of igf-binding protein for selective sensitization of target cells in vivo
AUPR030900A0 (en) * 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
US7081454B2 (en) 2001-03-28 2006-07-25 Bristol-Myers Squibb Co. Tyrosine kinase inhibitors
US7312215B2 (en) 2003-07-29 2007-12-25 Bristol-Myers Squibb Company Benzimidazole C-2 heterocycles as kinase inhibitors
US20100316639A1 (en) 2009-06-16 2010-12-16 Genentech, Inc. Biomarkers for igf-1r inhibitor therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310742A (en) * 1992-11-30 1994-05-10 Elias Alan N Uses for thioureylenes
WO1995016703A1 (en) * 1993-12-15 1995-06-22 Thomas Jefferson University Igf-1 analogs
US6015786A (en) * 1997-02-25 2000-01-18 Celtrix Pharmaceuticals, Inc. Method for increasing sex steroid levels using IGF or IGF/IGFBP-3

Also Published As

Publication number Publication date
WO2000020023A2 (en) 2000-04-13
WO2000020023A3 (en) 2000-07-06
EP1117424B1 (de) 2005-08-31
AU767141B2 (en) 2003-10-30
CA2345353C (en) 2009-07-07
DE69927041T2 (de) 2006-06-14
CA2345353A1 (en) 2000-04-13
HK1040906A1 (en) 2002-06-28
JP2003522110A (ja) 2003-07-22
AU6277899A (en) 2000-04-26
EP1117424A2 (de) 2001-07-25
ATE303159T1 (de) 2005-09-15
HK1040906B (zh) 2005-12-09

Similar Documents

Publication Publication Date Title
DE60045030D1 (de) Peptid yy (pyy) zur behandlung von glukose stoffwechselkrankheiten
IL254264A (en) Doses for treatments using anti-erbb2 antibodies
ATE382364T1 (de) Von igf-bindungsprotein stammendes peptid
ATE296839T1 (de) Antikörper zur krebsbehandlung und -diagnose
GEP20094798B (en) (s,s)-reboxetine for treating chronic pain
BR9714523A (pt) Tratamento de nefrite de lúpus com compostos anti-cd40l
WO1999057117A3 (de) Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
HUP9901908A2 (hu) p16 Expressziós konstrukciók és alkalmazásuk rákterápiában
DE69927041D1 (de) Null igf zur krebsbehandlung
PT951553E (pt) Proteinas de e4 de adenovirus para unducao de morte celular
DE69520430T2 (de) Meta substituierte arylalkylamine und therapeutische und diagnostische verwendung davon
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain
BR0212446A (pt) Uso de 4-piridilmetilftalazinas para tratamento de câncer
NO20020329D0 (no) Antitumor antistoffer, proteiner og anvendelser derav
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung
AU2346301A (en) Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases
MD743F1 (en) Remedy for immunity system and hormonal homeostasis normalization
GB9818650D0 (en) Therapeutic compounds and methods of making and using the same
MX9701832A (es) Nuevos profarmacos para la terapia de tumores y enfermedades inflamatorias.
RO86650B1 (ro) Preparat farmaceutic pentru tratarea dermatozelor
CO5170411A1 (es) Terapia para la leucemia mielocitica cronica
UA37104A (uk) Спосіб лікування гепатоцеребральної дистрофії (хвороби вільсона-коновалова)
UA30268A (uk) Фітозасіб, стимулюючий антитілогенез

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee